Aisling Capital as of Sept. 30, 2017
Portfolio Holdings for Aisling Capital
Aisling Capital holds 14 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 63.4 | $386M | 4.2M | 92.12 | |
| Aimmune Therapeutics | 12.2 | $74M | 3.0M | 24.79 | |
| Viewray (VRAYQ) | 7.1 | $43M | 7.5M | 5.76 | |
| Esperion Therapeutics (ESPR) | 6.9 | $42M | 837k | 50.12 | |
| Transenterix | 2.4 | $15M | 10M | 1.43 | |
| Adma Biologics (ADMA) | 1.8 | $11M | 3.6M | 3.08 | |
| Entellus Medical Cm | 1.6 | $9.8M | 529k | 18.46 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 1.4 | $8.3M | 1.0M | 8.10 | |
| Agile Therapeutics | 1.3 | $8.1M | 1.8M | 4.46 | |
| Syros Pharmaceuticals | 1.2 | $7.5M | 509k | 14.72 | |
| Chimerix (CMRX) | 0.4 | $2.5M | 473k | 5.25 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.2 | $1.1M | 2.5M | 0.42 | |
| Pernix Therapeutics Holdings | 0.1 | $662k | 210k | 3.15 | |
| Zeltiq Aesthetics | 0.0 | $0 | 12k | 0.00 |
